The Genomics of Drug Sensitivity in Cancer project from Weelcome Trust is an academic research program to identify molecular features of cancers that predict response to anti-cancer drugs. Participants are performing a large-scale drug screen incorporating detailed genomic and gene expression analyses to systematically identify drug response biomarkers. Registration not required.